|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.55 CAD | -4.18% |
|
+8.54% | +23.83% |
| 07-03 | COSCIENS Biopharma Completes Share Capital Amendment | MT |
| 06-18 | Cosciens Biopharma Inc. Announces Appointment of Peter H. Puccetti as Permanent CEO, Effective June 18, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| COSCIENS BIOPHARMA INC. | Other Biotechnology & Medical Research | -4.18% | +8.54% | +23.83% | -25.96% | -96.71% | 8.22M |  | |  |
- Stock Market
- Stocks
- CSCI Stock
- Charts COSCIENS Biopharma Inc.
- Comparison Chart
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
